These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35087751)

  • 41. Metabolism-associated molecular classification of cervical cancer.
    Zhao M; Zhang X; Huan Q; Dong M
    BMC Womens Health; 2023 Oct; 23(1):555. PubMed ID: 37884919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: A study based on TCGA and ICGC databases.
    Han Z; Wang H; Long J; Qiu Y; Xing XL
    Front Oncol; 2022; 12():931383. PubMed ID: 36091132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer.
    Chen X; Dong X; Li H; Wu T; Liu H; Wu J; Ge W; Hao L; Zhang Z
    Cancer Cell Int; 2024 Feb; 24(1):80. PubMed ID: 38383371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The immune landscape and prognostic analysis of CXCL8 immune-related genes in cervical squamous cell carcinoma.
    Zhang X; Yang J; Feng Q; Gu L; Qin G; Cheng C; Hou S; Shi Z
    Environ Toxicol; 2024 Apr; ():. PubMed ID: 38597597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.
    Chen H; Zhao X; Li Y; Zhang S; Wang Y; Wang L; Ma W
    Front Genet; 2022; 13():908807. PubMed ID: 35832191
    [No Abstract]   [Full Text] [Related]  

  • 46. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
    Gong M; Shen F; Li Y; Ming L; Hong L
    PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data.
    He Y; Hu S; Zhong J; Cheng A; Shan N
    PeerJ; 2020; 8():e10386. PubMed ID: 33344075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrated analysis of key microRNAs /TFs /mRNAs/ in HPV-positive cervical cancer based on microRNA sequencing and bioinformatics analysis.
    Yuan Y; Shi X; Li B; Peng M; Zhu T; Lv G; Liu L; Jin H; Li L; Qin D
    Pathol Res Pract; 2020 Jun; 216(6):152952. PubMed ID: 32307200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and Validation of Ferroptosis- and Immune-Related lncRNAs Signatures for Breast Infiltrating Duct and Lobular Carcinoma.
    Wei T; Zhu N; Jiang W; Xing XL
    Front Oncol; 2022; 12():844642. PubMed ID: 35444943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Construction of a prognostic model for non-small-cell lung cancer based on ferroptosis-related genes.
    Han K; Wang J; Qian K; Zhao T; Liu X; Zhang Y
    Biosci Rep; 2021 May; 41(5):. PubMed ID: 33988228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening of Significant Biomarkers Related to Prognosis of Cervical Cancer and Functional Study Based on lncRNA-associated ceRNA Regulatory Network.
    Ding H; Zhang L; Zhang C; Song J; Jiang Y
    Comb Chem High Throughput Screen; 2021; 24(3):472-482. PubMed ID: 32729415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 53. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma.
    Pan J; Xu L; Pan H
    Front Oncol; 2020; 10():1444. PubMed ID: 32974164
    [No Abstract]   [Full Text] [Related]  

  • 54. Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors.
    Han S; Wang S; Lv X; Li D; Feng Y
    Front Mol Biosci; 2023; 10():1188027. PubMed ID: 37187896
    [No Abstract]   [Full Text] [Related]  

  • 55. The Evaluation of Prognostic Value and Immune Characteristics of Ferroptosis-Related Genes in Lung Squamous Cell Carcinoma.
    Su J; Tan S; Gong H; Luo Y; Cheng T; Yang H; Wen X; Jiang Z; Li Y; Zhang L
    Glob Med Genet; 2023 Dec; 10(4):285-300. PubMed ID: 37915460
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of
    Zhao S; Yu M
    DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiogenesis-related lncRNAs index: A predictor for CESC prognosis, immunotherapy efficacy, and chemosensitivity.
    Huang X; Yi G; Xu J; Gou S; Chen H; Chen X; Quan X; Xie L; Teichmann AT; Yang G; Chi H; Wang Q
    J Cancer; 2024; 15(10):3095-3113. PubMed ID: 38706901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
    Li F; Ge D; Sun SL
    BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma.
    Wang Y; Chen W; Zhu M; Xian L
    Front Mol Biosci; 2021; 8():692530. PubMed ID: 34395526
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of molecular subtypes, prognostic status and immunotherapy response in cervical cancer based on angiogenic signature genes.
    Deng Z; Zhang L; Sun C; Liu Y; Li B
    Heliyon; 2024 Oct; 10(19):e38488. PubMed ID: 39391470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.